Rani Therapeutics Files 8-K
Ticker: RANI · Form: 8-K · Filed: Jul 23, 2024 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | 8-K |
| Filed Date | Jul 23, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.0001, $3.08, $3.0799, $10.0 m, $50,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-event
TL;DR
RANI filed an 8-K on 7/23 for an event on 7/22. Check for details.
AI Summary
Rani Therapeutics Holdings, Inc. filed an 8-K on July 23, 2024, reporting an event that occurred on July 22, 2024. The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits'. The company is incorporated in Delaware and its principal executive offices are located in San Jose, California.
Why It Matters
This filing indicates a significant event or update from Rani Therapeutics Holdings, Inc., requiring disclosure to the public and investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K current report, which typically contains routine disclosures rather than immediate high-risk events.
Key Numbers
- 001-40672 — SEC File Number (Identifies the company's filing with the SEC)
- 86-3114789 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- July 22, 2024 (date) — Earliest event reported
- July 23, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- San Jose, California (location) — Principal executive offices
FAQ
What specific event triggered this 8-K filing?
The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits', but the specific event is not detailed in the provided header information.
When was the earliest event reported in this filing?
The earliest event reported was on July 22, 2024.
What is Rani Therapeutics Holdings, Inc.'s state of incorporation?
Rani Therapeutics Holdings, Inc. is incorporated in Delaware.
Where are Rani Therapeutics Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at 2051 Ringwood Avenue, San Jose, California, 95131.
What is the SEC file number for Rani Therapeutics Holdings, Inc.?
The SEC file number for Rani Therapeutics Holdings, Inc. is 001-40672.
Filing Stats: 1,352 words · 5 min read · ~5 pages · Grade level 12.3 · Accepted 2024-07-23 06:06:57
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share RANI The Nasdaq Stock Mar
- $3.08 — ance and will have an exercise price of $3.08 per share. The Series B common warrants
- $3.0799 — or in the case of pre-funded warrants, $3.0799 per pre-funded warrant and accompanying
- $10.0 m — fering are expected to be approximately $10.0 million, before deducting placement agent
- $50,000 — cement agent in an amount not to exceed $50,000. The Offering is being made pursuant
Filing Documents
- d873880d8k.htm (8-K) — 35KB
- d873880dex41.htm (EX-4.1) — 75KB
- d873880dex42.htm (EX-4.2) — 78KB
- d873880dex43.htm (EX-4.3) — 73KB
- d873880dex51.htm (EX-5.1) — 15KB
- d873880dex101.htm (EX-10.1) — 168KB
- g873880g0722220513587.jpg (GRAPHIC) — 2KB
- 0001193125-24-182549.txt ( ) — 689KB
- rani-20240722.xsd (EX-101.SCH) — 3KB
- rani-20240722_lab.xml (EX-101.LAB) — 18KB
- rani-20240722_pre.xml (EX-101.PRE) — 11KB
- d873880d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Rani Therapeutics Holdings, Inc. Date: July 23, 2024 By: /s/ Svai Sanford Svai Sanford Chief Financial Officer